loading
前日終値:
$0.775
開ける:
$0.76
24時間の取引高:
229.84K
Relative Volume:
0.31
時価総額:
$97.09M
収益:
$140.46M
当期純損益:
$-146.34M
株価収益率:
-0.5833
EPS:
-1.32
ネットキャッシュフロー:
$-117.73M
1週間 パフォーマンス:
-7.97%
1か月 パフォーマンス:
-9.81%
6か月 パフォーマンス:
-31.20%
1年 パフォーマンス:
+4.39%
1日の値動き範囲:
Value
$0.76
$0.798
1週間の範囲:
Value
$0.7518
$0.8886
52週間の値動き範囲:
Value
$0.6174
$1.95

Karyopharm Therapeutics Inc Stock (KPTI) Company Profile

Name
名前
Karyopharm Therapeutics Inc
Name
セクター
Healthcare (1195)
Name
電話
617-658-0600
Name
住所
85 WELLS AVENUE, NEWTON, MA
Name
職員
325
Name
Twitter
@Karyopharm
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
KPTI's Discussions on Twitter

KPTI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
KPTI 0.77 97.09M 140.46M -146.34M -117.73M -1.32
VRTX 449.35 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.23 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 588.75 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.29 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.11 24.89B 3.30B -501.07M 1.03B 11.54

Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-01-19 開始されました Piper Sandler Overweight
2022-11-04 アップグレード RBC Capital Mkts Sector Perform → Outperform
2022-02-09 アップグレード JP Morgan Underweight → Neutral
2021-11-19 再開されました Morgan Stanley Equal-Weight
2021-08-06 ダウングレード JP Morgan Overweight → Neutral
2021-08-06 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2021-08-06 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-07-02 開始されました Morgan Stanley Overweight
2020-03-04 開始されました Barclays Overweight
2020-01-17 ダウングレード Wedbush Outperform → Neutral
2019-07-23 アップグレード JP Morgan Neutral → Overweight
2019-07-05 繰り返されました H.C. Wainwright Buy
2019-07-05 繰り返されました Robert W. Baird Outperform
2019-03-01 ダウングレード JP Morgan Overweight → Neutral
2019-02-28 繰り返されました BofA/Merrill Underperform
2019-02-27 ダウングレード BofA/Merrill Neutral → Underperform
2019-01-03 アップグレード BofA/Merrill Underperform → Neutral
2018-12-03 開始されました B. Riley FBR Buy
2018-11-09 アップグレード Wedbush Neutral → Outperform
2018-05-24 ダウングレード Wedbush Outperform → Neutral
2018-04-02 再開されました Leerink Partners Outperform
2017-11-15 再開されました H.C. Wainwright Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2016-09-08 繰り返されました H.C. Wainwright Buy
2016-08-30 アップグレード Jefferies Hold → Buy
2016-08-18 開始されました H.C. Wainwright Buy
2016-06-28 開始されました Robert W. Baird Outperform
すべてを表示

Karyopharm Therapeutics Inc (KPTI) 最新ニュース

pulisher
03:42 AM

Karyopharm gains after changes to late-stage trial - MSN

03:42 AM
pulisher
Nov 20, 2024

Karyopharm appoints new chief accounting officer - Investing.com India

Nov 20, 2024
pulisher
Nov 20, 2024

Karyopharm Therapeutics Appoints New Chief Accounting Officer - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Karyopharm appoints Kristin Abate as Chief Accounting Officer - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Karyopharm appoints new chief accounting officer By Investing.com - Investing.com UK

Nov 20, 2024
pulisher
Nov 20, 2024

Karyopharm Therapeutics Inc. Appoints Kristin Abate as Chief Accounting Officer - Marketscreener.com

Nov 20, 2024
pulisher
Nov 18, 2024

Karyopharm to Present New Selinexor Clinical Data at ASH 2024 Annual Meeting | KPTI Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 15, 2024

Avidity Partners Management LP's Strategic Acquisition of Karyop - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress By Investing.com - Investing.com Nigeria

Nov 14, 2024
pulisher
Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Rating Upgraded by StockNews.com - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

GSA Capital Partners LLP Purchases 792,283 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat

Nov 14, 2024
pulisher
Nov 08, 2024

Leerink Partnrs Issues Optimistic Forecast for KPTI Earnings - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

What is HC Wainwright's Estimate for KPTI FY2024 Earnings? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Karyopharm Therapeutics Falls To US$0.88, But Insiders Sold At Lower Price - Simply Wall St

Nov 08, 2024
pulisher
Nov 08, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

Nov 08, 2024
pulisher
Nov 08, 2024

Karyopharm Therapeutics Reports Q3 2024 Financial Results and Corporate Progress - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

Karyopharm Therapeutics Inc (KPTI) Is Worth Accumulating At Current Levels - Stocks Register

Nov 07, 2024
pulisher
Nov 07, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024
pulisher
Nov 06, 2024

Karyopharm stock price target raised, overweight on revenue beat - Investing.com India

Nov 06, 2024
pulisher
Nov 06, 2024

Karyopharm therapeutics CEO Richard Paulson sells $3,346 in stock - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Karyopharm therapeutics CEO Richard Paulson sells $3,346 in stock By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

Karyopharm stock price target raised, overweight on revenue beat By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 06, 2024

Earnings call: Karyopharm Therapeutics reports on clinical and financial progress - Investing.com Nigeria

Nov 06, 2024
pulisher
Nov 06, 2024

Piper Sandler Boosts Karyopharm Therapeutics (NASDAQ:KPTI) Price Target to $5.00 - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Karyopharm price target raised to $5 from $4 at Piper Sandler - TipRanks

Nov 06, 2024
pulisher
Nov 06, 2024

Karyopharm Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlig - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Karyopharm Therapeutics' SWOT analysis: oncology firm's stock faces pivotal year - Investing.com Australia

Nov 06, 2024
pulisher
Nov 06, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

Karyopharm Therapeutics Inc. Reports Q3 2024 Earnings - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Karyopharm Therapeutics Q3 2024 Earnings Preview - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript - AOL

Nov 05, 2024
pulisher
Nov 05, 2024

Karyopharm Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 05, 2024
pulisher
Nov 05, 2024

Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings: EPS Loss of - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Karyopharm Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 05, 2024
pulisher
Nov 05, 2024

Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress - PR Newswire

Nov 05, 2024
pulisher
Nov 04, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com

Nov 04, 2024
pulisher
Nov 02, 2024

KPTIKaryopharm Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Nov 02, 2024
pulisher
Nov 02, 2024

Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WV News

Nov 01, 2024
pulisher
Nov 01, 2024

Karyopharm Therapeutics (KPTI) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Karyopharm Therapeutics' (KPTI) Buy Rating Reiterated at HC Wainwright - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Karyopharm updates SENTRY trial endpoints, eyes 2025 data - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

Karyopharm updates SENTRY trial endpoints, eyes 2025 data By Investing.com - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Karyopharm stock gains as late-stage trial changes (KPTI:NASDAQ) - Seeking Alpha

Oct 31, 2024

Karyopharm Therapeutics Inc (KPTI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):